Angioplasty Balloons Market Insights: Advancing Global Health Security & Innovation 2035
Angioplasty balloons are single-use, catheter-mounted medical devices used during percutaneous transluminal angioplasty procedures to dilate narrowed or occluded blood vessels (coronary and peripheral). The product family spans simple plain-old-balloon angioplasty (POBA) devices, drug-eluting balloons (DEBs), cutting/scoring balloons and other specialty designs engineered for specific lesion types and anatomical locations. The market mixes commodity-like volume for routine POBA devices with higher-margin, innovation-driven segments such as DEBs and specialty balloons aimed at restenosis-prone lesions . The Angioplasty Balloons Market was valued at USD 3.6 billion in 2025 and is projected to reach USD 5.5 billion by the end of 2035 , representing a CAGR of 4.1% for the forecast period 2026–2035. Angioplasty Balloons Industry Demand Key practical advantages that underpin purchasing and clinical adoption include: · Cost-ef...